Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Posted on: July 11, 2018, 7:16 a.m.
Antiva Biosciences Closes $15 Million Series C-1 FinancingHillhouse, an investor with deep experience in China, led the round. Funding will accelerate additional clinical trials SOUTH SAN FRANCISCO, Calif., July 10, 2018-- Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection, has raised $15 million in Series C-1 financing led by Hillhouse Capital Management. Sirona Capital, along with existing investors Canaan Partners, Sofinnova Ventures, Brace Pharma Capital, Osage ... Full investment news articleRelevent to this post: UCSF Foundation Lumira Capital Corp,